The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Inhibition of glucose metabolism through treatment of BRAF mutated metastatic melanoma with vemurafenib.

Govind  Warrier

No Relationships to Disclose

Lilibeth  Lanceta

No Relationships to Disclose

Yoannis  Imbert-Fernandez

No Relationships to Disclose

Jason Alan  Chesney

Consulting or Advisory Role - Amgen; Replimune

Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; MedImmune; MedImmune; Replimune

Patents, Royalties, Other Intellectual Property - University of Louisville US Patents

Travel, Accommodations, Expenses - Amgen; Replimune